About

Bio

Impact Factor: 4.286 Circulation: The Publisher does not disclose the circulation. Affiliations: Oral Oncology is the official journal of the European Association of Oral Medicine, International Association of Oral Pathologists, and the International Academy of Oral Oncology. Aims of the journal: Oral Oncology - A Journal Related to Head & Neck Oncology, is an international interdisciplinary journal which seeks to publish high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck. Readership: Oral Oncology aims to be of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields. Content: Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes): Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral healthcare Quality of life issues; issues of consent; psycho

Email

email@cision.one

Website

site@cision.one

Social media

linkedin x facebook reddit

Location

United Kingdom

Frequency

upgrade

Circulation

upgrade

Sectors

Oncology


Is this you? We'd love to hear from you, contact our journalist team.
Contact us to unlock the full profile

Most recent articles by Oral Oncology

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet
Contact us to explore recent articles

Explore outlets similar to Oral Oncology

  • OncologyLive
    OncologyLive

    Established in 2000 as Oncology Net Guide and rebranded in March 2011 as OncLive. Written for physicians to enable them to keep up to date with the rapidly expanding amount of medical information and resources on oncology. Designed as a handbook for frequent referencing and written in an easy-to-understand style. Articles are quick-reading, timely, provides practical information and information about new medical treatments. Media Alert: Tuesday April 12th 2011 Oncology Net Guide has changed its name to OncLive. Anita Shaffer is Associate Editor in charge of the oncology research and technology magazine. She may be reached at +1 (609) 716 7777 Ext 192 and ashaffer@onclive.com

    View
  • Targeted Oncology
    Targeted Oncology

    Targeted Oncology is an online resource for oncology news and research, carrying content from Intellisphere's printed oncology journals, Targeted Therapies and The Journal of Targeted Therapies.

    View
  • Medical News Today
    Medical News Today

    Background and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.

    View
  • ASH Clinical News
    ASH Clinical News

    ASH Clinical News is a news publication from the American Society of Hematology and serves as a source for worldwide news and perspectives on hematology and oncology. Coverage includes blood disorders and related topics of interest to hematologists, including developments in oncology, endocrinology and cardiology. Each month it provides the latest updates in the field along with perspectives and opinions from key leaders as well as tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.

    View
  • The Lancet Oncology
    The Lancet Oncology

    Impact Factor: 26.509 (Source:Thomson Reuters Journal Citation 2016) Format and Background: The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Circulation: The Publisher does not disclose the circulation. Aims of the journal: The Lancet Oncology was launched in September 2000 with the aim of being a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. In May 2005, the journal expanded to include original research and began publishing articles online first prior to print publication. In 2008, the journal expanded its online presence to include regular podcasts. The aim of The Lancet Oncology is to publish interesting, informative, and practice-changing articles on any topic connected with clinical oncology. Readership: Clinical cancer specialists worldwide. Content: Topics include, but are not limited to: Breast cancer Endocrine system cancer Gastrointestinal cancer Genitourinary cancer Gynaecological cancer Haematological cancer Head and neck cancer Neurooncology Paediatric oncology Thoracic oncology Sarcoma Skin cancer Epidemiology, cancer prevention, and cancer control Supportive care Imaging Health-care systems Manuscript submission: The journal publishes a range of article types that encompass all aspects of oncological medicine: Comment, Correspondence, News, Cancer and Society, Article, Meta-analysis, Review, Historical Review, Health-care Development, Personal View, and Debate. For further information for authors, click here. Online manuscripts submission here. Ad Rates: Can be viewed here the advertising team can be reached at lancet-ads@elsevier.com Other Information: The RSS feed can be viewed here Podcasts can be found here Information for the press can be viewed here

    View
Use CisionOne to find more relevant outlets

Contact Oral Oncology and get access to over 850K accurate, up-to-date media profiles.

Discover the stories that impact your brand. In realtime.

CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.